1. 1) Nabeshima T, Sugiura S, Nakanishi H, Tanimura M, Hashida T, Shouji T, Nakao M, “Injection, anticancer drug sterility preparation guidelines” edited by the Japanese Society of Hospital Pharmacists, Yakuji Nippo, Tokyo, 2008, pp23-35.
2. 2) Sato J, Kikuchi S, Kudo K, Adsorptive evaluation of the working sheet to use at anticancer drug preparation. J Jpn Soc Hosp Pharm, 2014, 50, 1040-1043.
3. 4) Hama T, Aoyama T, Shirai T, Higuchi S, Yokokawa T, Sugimoto Y, Environmental Contamination due to Preparation of Cyclophosphamide and Exposure of Pharmacists to It, Jpn J Pharm Health Care Sci, 2009, 35, 693-700.
4. 5) Yoshida J, Komori K, Mochizuki C, Nakata Y, Tei G, Masu Y, Koda S, Nishida S, Evaluation of the Safety Precaution to Occupational Exposure to Antineoplastic Drugs in the Department of Pharmacy, Jpn J Pharm Health Care Sci, 2013, 39, 1-9.
5. 6) Sato J, Mori M, Kumagai M, Nakayama S, Yamauchi S, Kudo K, Takahashi K, The usefulness of a closed preparation system, Chemosafe, for anticancer drugs, J Jpn Soc Hosp Pharm, 2012, 48, 441-444.